Pendopharm-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pendopharm - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014185
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PendoPharm is a healthcare company that offers production and commercialization of a wide range of drugs. The company’s products comprise spans prescription drugs, over-the-counter and behind-the-counter products. Its prescription products offers drugs for therapeutic areas of gastroenterology, orthopedics and urology. Its OTC and BTC products provide allergy, analgesics, cough, cold and sinus, gastroenterology, nasal care and pediatric drugs. The company also offers licensing, development and marketing late-stage specialty prescription medicines and consumer brands. It markets its products across Canada. Pendopharm is headquartered in Montreal, Quebec, Canada.

Pendopharm – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pendopharm, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pendopharm, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pendopharm, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pendopharm, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pendopharm, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pendopharm, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
PendoPharm Enters into Distribution Agreement with Tillotts Pharma 10
Anika Therapeutics Enters into Agreement with PendoPharm 11
Pendopharm Enters into Distribution Agreement with Sanofi-aventis Canada 12
Licensing Agreements 13
Pendopharm Enters into Licensing Agreement with Edesa Biotech 13
Sigmoid Pharma Enters into Licensing Agreement with PendoPharm for CyCol 14
Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 15
Equity Offering 16
Sigmoid Pharma Raises USD6.3 Million in Private Placement 16
Pendopharm – Key Competitors 17
Pendopharm – Key Employees 18
Pendopharm – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product News 20
Aug 17, 2017: Introducing the new Lax-A product line for relief of occasional constipation 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Pendopharm, Pharmaceuticals & Healthcare, Key Facts 2
Pendopharm, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pendopharm, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pendopharm, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pendopharm, Deals By Therapy Area, 2011 to YTD 2017 8
Pendopharm, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PendoPharm Enters into Distribution Agreement with Tillotts Pharma 10
Anika Therapeutics Enters into Agreement with PendoPharm 11
Pendopharm Enters into Distribution Agreement with Sanofi-aventis Canada 12
Pendopharm Enters into Licensing Agreement with Edesa Biotech 13
Sigmoid Pharma Enters into Licensing Agreement with PendoPharm for CyCol 14
Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 15
Sigmoid Pharma Raises USD6.3 Million in Private Placement 16
Pendopharm, Key Competitors 17
Pendopharm, Key Employees 18

★海外企業調査レポート[Pendopharm-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Green Dot Corporation:企業の戦略・SWOT・財務情報
    Green Dot Corporation - Strategy, SWOT and Corporate Finance Report Summary Green Dot Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bta Bank Jsc:企業の戦略・SWOT・財務分析
    Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report Summary Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Wells Fargo Clearing Services LLC:企業の戦略・SWOT・財務分析
    Wells Fargo Clearing Services LLC - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Clearing Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Animal Health International Inc:企業の戦略的SWOT分析
    Animal Health International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Athera Biotechnologies AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Athera Biotechnologies AB (Athera) is a clinical stage biopharmaceutical company that focuses on the development of anti-inflammatory biological candidate drugs for the prevention and treatment of immunovascular disease. The company develops a proprietary clinical development stage program, …
  • Stabilis Solutions Inc (AETI):企業の財務・戦略的SWOT分析
    Summary Stabilis Solutions Inc (Stabilis Solutions) formerly, Stabilis Energy Inc a subsidiary of Amnor Technologies Inc, is a provider of power delivery solutions. The company's products comprise power distribution and power conversion products. Stabilis Solutions power distribution products compri …
  • Sonoma Pharmaceuticals Inc (SNOA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Critical Outcome Technologies Inc (COT)-製薬・医療分野:企業M&A・提携分析
    Summary Critical Outcome Technologies Inc (COTI) is a biopharmaceutical company that develops targeted therapeutics with focus on oncology. The company’s lead program COTI-2 is a novel small molecule activator of misfolded mutant p53 proteins for the treatment of ovarian and other gynecological canc …
  • Centrais Eletricas de Santa Catarina SA (CLSC4):企業の財務・戦略的SWOT分析
    Centrais Eletricas de Santa Catarina SA (CLSC4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Lung Biotechnology PBC:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Biotechnology PBC (LBI), formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company provides product such as Adcirca and Tyvas …
  • Topy Industries Ltd:企業の戦略・SWOT・財務分析
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mirvac Group:企業の戦略・SWOT・財務情報
    Mirvac Group - Strategy, SWOT and Corporate Finance Report Summary Mirvac Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Central Iowa Power Cooperative:企業の戦略的SWOT分析
    Central Iowa Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Esso (Thailand) PCL (ESSO):企業の財務・戦略的SWOT分析
    Esso (Thailand) PCL (ESSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Carrizo Oil & Gas Inc (CRZO):石油・ガス:M&Aディール及び事業提携情報
    Summary Carrizo Oil & Gas Inc (Carrizo) is an independent oil and gas company, which carries out exploration, development and production of oil and natural gas from several resources plays. It has presence in the Eagle Ford Shale in South Texas and the Delaware Basin in West Texas. The company princ …
  • Taylor Morrison Home Corp:企業の戦略・SWOT・財務分析
    Taylor Morrison Home Corp - Strategy, SWOT and Corporate Finance Report Summary Taylor Morrison Home Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cancer Research Technology Ltd.:企業のM&A・事業提携・投資動向
    Cancer Research Technology Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cancer Research Technology Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Shaw Communications Inc (SJR.B):企業の財務・戦略的SWOT分析
    Shaw Communications Inc (SJR.B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Eli Lilly and Co (LLY):医療機器:M&Aディール及び事業提携情報
    Summary Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. It als …
  • Kuraray Co Ltd (3405):企業の財務・戦略的SWOT分析
    Kuraray Co Ltd (3405) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆